TP53 and neoplasm: Unlike other tumor suppressors, mutant p53 protein can also acquire a gain-of-function which contributes to aggressive tumor phenotypes, including enhanced invasion, genomic instability, and therapy resistance (Muller and Vousden, 2014; Dittmer et al., 1993; Lang et al., 2004; Xu et al., 2011).